Table 5.
Baseline median (IQR) | Placebo median (IQR) | Drug median (IQR) | Placebo pain difference median (IQR) | Drug pain difference median (IQR) | P-value* | |
---|---|---|---|---|---|---|
Physical function (PF) | 20(10) | 25(13.75) | 35(5) | 5(10) | 15(18.75) | .018 |
Role Functioning (RF) | 25(25) | 25(50) | 50(0) | 0(25) | 25(53.75) | .026 |
Bodily pain (BP) | 31(10) | 41(16.50) | 62(18.50) | 11(10.50) | 30.5(19.25) | .001 |
General health (GH) | 20(12) | 35(28.75) | 53.50(32.50) | 10(19.50) | 29(16) | .001 |
Vitality (V) | 27.50(8.75) | 35(23.75) | 55(28.75) | 10(15) | 25(8.75) | .002 |
Social functioning (SF) | 37.50(25) | 50(9.37) | 75(21.87) | 12.50(12.50) | 25(7.50) | .005 |
Role-emotional (RE) | 33.30(33.30) | 66.70(33.40) | 33.30(33.40) | 33.30(33.40) | 16.65(33.30) | .333 |
Mental health (ME) | 32(8) | 42(18) | 58(31) | 8(9.50) | 24(22.50) | .002 |
Physical component summary (PCS) | 26.05(5.05) | 29.80(8.6) | 38.35(11.85) | 3.10(6.47) | 11.45(12.27) | .001 |
Mental component summary (MCS) | 31.25(7.47) | 39.70(8.9) | 43.50(10.65) | 5.55(5.77) | 11.10(6.67) | .012 |
Data are presented as median (interquartile range)
* P-value for drug difference and placebo difference according to Wilcoxon Signed Rank test
There is no difference in the baseline values between the two groups since it is a crossover study